Millstone Evans Group, LLC Bristol Myers Squibb CO Transaction History
Millstone Evans Group, LLC
- $147 Billion
- Q4 2024
A detailed history of Millstone Evans Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Millstone Evans Group, LLC holds 6,373 shares of BMY stock, worth $376,070. This represents 0.25% of its overall portfolio holdings.
Number of Shares
6,373Holding current value
$376,070% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,763Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.36 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.67 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.61 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.56 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...